• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10621
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Arteriosclerosis/ Atherosclerosis (4437)
Event Date 11/01/2023
Event Type  Injury  
Event Description
Synergy china registry.It was reported that subject presented with coronary atherosclerotic cardiopathy.In (b)(6) 2020, the subject was referred for cardiac catheterization and on the same day index procedure was performed.The target lesion#1 was located in the proximal left anterior descending artery (lad) with 75% stenosis and was 28 mm long, with a reference vessel diameter of 2.5 mm.The target lesion#1 was treated with pre-dilatation and placement of a 2.50 mm x 28 mm synergy stent system.Following post-dilatation, the residual stenosis was 0%.The target lesion#2 was located in the middle lad extending up to distal lad with 85 % stenosis and was 38 mm long with a reference vessel diameter of 3.0 mm.The target lesion#2 was treated with pre-dilatation and placement of a 3.00 mm x 38 mm synergy stent system.Following post-dilatation, the residual stenosis was 0%.Six days later, the subject was discharged on aspirin and clopidogrel.In (b)(6) 2023, the subject presented with coronary atherosclerotic cardiopathy and was hospitalized on the same day for further treatment.Medication was given to treat the event.Three days later, the subject was discharged on aspirin and ticagrelor.At the time of reporting the event was considered to be recovering/ resolving.
 
Manufacturer Narrative
E1 initial reporter phone: (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18307823
MDR Text Key330220932
Report Number2124215-2023-68536
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/11/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/21/2020
Device Model Number10621
Device Catalogue Number10621
Device Lot Number0023749656
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/28/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/25/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age54 YR
Patient SexMale
-
-